Morpholino

MO3-cpn1

ID
ZDB-MRPHLNO-180126-1
Name
MO3-cpn1
Previous Names
  • cpn1 ATG MO (1)
Target
Sequence
5' - GAGCTGCCTGACAGCATGGTCCCA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO3-cpn1
Phenotype
Phenotype resulting from MO3-cpn1
Phenotype Fish Figures
blood circulation decreased process quality, abnormal sd2Tg; y1Tg + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
caudal vein plexus flt4 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
caudal vein plexus stab2 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
caudal vein plexus mrc1a expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
caudal vein plexus kdrl expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
caudal vein plexus morphology, abnormal sd2Tg; y1Tg + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
caudal vein plexus blood vessel development process quality, abnormal y1Tg + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
dorsal aorta kdrl expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
dorsal aorta efnb2a expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
dorsal aorta stab2 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
intersegmental vessel flt4 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
intersegmental vessel kdrl expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
intersegmental vessel morphology, abnormal sd2Tg; y1Tg + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
intersegmental vessel blood vessel development process quality, abnormal y1Tg + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
intersegmental vessel cell migration involved in sprouting angiogenesis decreased efficacy, abnormal y1Tg + MO3-cpn1 Fig. 3 with image from Wu et al., 2017
intersegmental vessel endothelial cell decreased amount, abnormal ci5Tg; y7Tg + MO3-cpn1 Fig. 3 with image from Wu et al., 2017
intersegmental vessel sprouting angiogenesis process quality, abnormal y1Tg + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
pericardial region edematous, abnormal TL + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
trunk cell population proliferation decreased occurrence, abnormal la116Tg + MO3-cpn1 Fig. 3 with image from Wu et al., 2017
trunk vasculature flt4 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
trunk vasculature kdrl expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
trunk vasculature mrc1a expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
trunk vasculature stab2 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
trunk vasculature blood circulation decreased process quality, abnormal sd2Tg; y1Tg + MO3-cpn1 Fig. 2 with image from Wu et al., 2017
whole organism efnb2a expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
whole organism flt4 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
whole organism id1 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 7 with image from Wu et al., 2017
whole organism mrc1a expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
whole organism stab2 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 4 with image from Wu et al., 2017
whole organism hey2 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 7 with image from Wu et al., 2017
whole organism eve1 expression decreased amount, abnormal TL + MO3-cpn1 Fig. 7 with image from Wu et al., 2017
Phenotype of all Fish created by or utilizing MO3-cpn1
Phenotype Fish Conditions Figures
caudal vein plexus kdrl expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
whole organism mrc1a expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
whole organism stab2 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
whole organism flt4 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
whole organism eve1 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 7 with image from Wu et al., 2017
whole organism id1 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 7 with image from Wu et al., 2017
dorsal aorta stab2 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
caudal vein plexus mrc1a expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
caudal vein plexus stab2 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
trunk vasculature kdrl expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
intersegmental vessel kdrl expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
trunk vasculature stab2 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
whole organism id1 expression decreased amount, abnormal TL + MO3-cpn1 chemical treatment by environment: dorsomorphin Fig. 7 with image from Wu et al., 2017
whole organism efnb2a expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
caudal vein plexus flt4 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
dorsal aorta efnb2a expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
dorsal aorta kdrl expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
trunk vasculature flt4 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
trunk vasculature mrc1a expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
pericardial region edematous, abnormal TL + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
whole organism hey2 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 7 with image from Wu et al., 2017
intersegmental vessel flt4 expression decreased amount, abnormal TL + MO3-cpn1 control Fig. 4 with image from Wu et al., 2017
intersegmental vessel sprouting angiogenesis process quality, abnormal la116Tg + MO3-cpn1 chemical treatment by environment: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor Fig. 6 with image from Wu et al., 2017
intersegmental vessel morphology, abnormal la116Tg + MO3-cpn1 chemical treatment by environment: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor Fig. 6 with image from Wu et al., 2017
intersegmental vessel blood vessel development process quality, abnormal la116Tg + MO3-cpn1 chemical treatment by environment: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor Fig. 6 with image from Wu et al., 2017
caudal vein plexus morphology, abnormal la116Tg + MO3-cpn1 chemical treatment by environment: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor Fig. 6 with image from Wu et al., 2017
caudal vein plexus blood vessel development process quality, abnormal la116Tg + MO3-cpn1 chemical treatment by environment: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor Fig. 6 with image from Wu et al., 2017
trunk cell population proliferation decreased occurrence, abnormal la116Tg + MO3-cpn1 control Fig. 3 with image from Wu et al., 2017
caudal vein plexus morphology, abnormal y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel sprouting angiogenesis process quality, abnormal y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel blood vessel development process quality, abnormal y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel morphology, abnormal y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel cell migration involved in sprouting angiogenesis decreased efficacy, abnormal y1Tg + MO3-cpn1 control Fig. 3 with image from Wu et al., 2017
caudal vein plexus blood vessel development process quality, abnormal y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel endothelial cell decreased amount, abnormal ci5Tg; y7Tg + MO3-cpn1 control Fig. 3 with image from Wu et al., 2017
caudal vein plexus morphology, abnormal sd2Tg; y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
blood circulation decreased process quality, abnormal sd2Tg; y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel blood vessel development process quality, abnormal sd2Tg; y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel sprouting angiogenesis process quality, abnormal sd2Tg; y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
trunk vasculature blood circulation decreased process quality, abnormal sd2Tg; y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
intersegmental vessel morphology, abnormal sd2Tg; y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
caudal vein plexus blood vessel development process quality, abnormal sd2Tg; y1Tg + MO3-cpn1 control Fig. 2 with image from Wu et al., 2017
Citations